Welcome to our dedicated page for FLOWERS FOODS SEC filings (Ticker: FLO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Flowers Foods filings document the public-company record for a Georgia packaged bakery producer whose common stock trades on the New York Stock Exchange under FLO. The company's 8-K reports cover operating results, financial condition, guidance, debt and credit agreements, and material corporate events affecting its brand portfolio and operating structure.
Proxy and governance filings describe director elections, board composition, executive compensation, shareholder voting matters, and human-capital or change-in-control plans. Recent disclosures also record leadership-transition matters, the Simple Mills acquisition as part of the company's strategic priorities, and financing arrangements tied to senior notes, a term loan facility and the revolving credit facility.
Flowers Foods, Inc. director reported equity transactions and updated holdings. On 01/01/2026, the director converted 7,196 deferred stock units into common stock at a price of $0, and also acquired 1,146 additional deferred stock units representing dividend equivalents that will settle in common stock.
After these transactions, the director beneficially owned 98,731.1029 shares of Flowers Foods common stock directly and 100 shares indirectly through a child. The derivative awards were granted under the company’s 2014 Omnibus Equity and Incentive Compensation Plan and certain deferred share awards have no expiration date and no exercise price under the applicable Deferred Shares Agreement for Directors.
Flowers Foods, Inc. reported an equity award to one of its directors. On 01/01/2026, the director received 9,191 units of deferred stock under the Flowers Foods, Inc. 2014 Omnibus Equity and Incentive Compensation Plan, as amended effective May 25, 2023.
The deferred stock is reported as a derivative security with a stated price of $0, consistent with non-cash director equity compensation. The award has no conversion or exercise price and no expiration date under the company’s Deferred Shares Agreement for Directors. Following this grant, the director beneficially owns 9,191 derivative securities, held directly.
Flowers Foods disclosed that one of its directors made several gifts of company common stock on December 15, 2025.
The director gifted 1,363 shares to his daughter and 1,363 shares to his son, all at a price of $0 per share, and also reported another gift of 272 shares. After these transactions, he beneficially owns 529,478 shares directly, including 460,383 shares held in a trust of which he is the sole beneficiary, plus 2,993.152 shares indirectly through his daughter and 1,363 shares indirectly through his son. The daughter’s indirect holdings include shares acquired through reinvestment of dividends based on a statement dated December 12, 2025.
Flowers Foods, Inc. director reported a small open-market purchase of company stock. On 12/03/2025, a transaction coded "P" shows the acquisition of 456.1606 shares of common stock at a price of $10.9 per share, held indirectly by the director’s spouse as custodian for a minor grandchild. After this transaction, the filing shows 547.4932 shares held indirectly in that custodial account and 44,334.5803 shares held directly. A footnote states that the total indirect position includes shares acquired through dividend reinvestment and that beneficial ownership of the custodial shares is disclaimed.
Flowers Foods, Inc. (FLO) reported that its Compensation and Human Capital Committee approved an amended and restated Change of Control Plan on November 13, 2025. The plan covers the company’s named executive officers as disclosed in its April 8, 2025 proxy statement.
The changes add a new severance feature giving participants a prorated annual bonus at the target level for the year their employment ends in connection with a qualifying change of control. The amendment also revises the lump-sum payment meant to cover medical costs so it equals the participant’s full monthly COBRA amount multiplied by the greater of 18 or the participant’s severance multiple under the plan multiplied by 12.
In addition, the definitions of “Change of Control” and “Good Reason” are revised to match those in the company’s 2014 Omnibus Equity and Incentive Compensation Plan and related awards. The restrictive covenants are moved into a separate form of separation agreement that participants must sign to receive severance benefits.
Flowers Foods, Inc. filed a current report describing that it released financial results for its latest period. On November 6, 2025, the company issued a press release covering its financial condition and results of operations for the 12 weeks ended October 4, 2025. The press release is attached as an exhibit to provide full details of sales, profits, and other performance measures for that period.
Flowers Foods (FLO) reported Q3 results. Net sales were $1,226,554 and net income was $39,534, or $0.19 per share, versus $1,190,561 and $64,984 ($0.31 per share) a year ago. Year‑to‑date net sales reached $4,023,619 with operating cash flow of $320,823.
The company completed the $848.6 million acquisition of Simple Mills, recording $367.9 million of goodwill and $533.2 million of identifiable intangibles. In Q3, Simple Mills contributed $70.7 million of net sales and a $2.0 million net loss. Q3 included $5,510 of restructuring charges and $1,735 of acquisition and integration costs.
Total assets rose to $4,349,618 from $3,400,447 at year‑end, with current maturities of long‑term debt at $399,433 and noncurrent long‑term debt at $1,380,190. Walmart/Sam’s Club represented 21.2% of Q3 net sales. The company paid a quarterly dividend of $0.2475 per share.
Flowers Foods (FLO) appointed D. Anthony Scaglione as Chief Financial Officer, effective January 1, 2026. He will serve as the company’s principal financial officer and principal accounting officer.
Compensation includes a base salary of $785,000, an annual cash bonus target equal to 100% of salary beginning in fiscal 2026, and long-term incentives targeted at 210% of salary, delivered as performance shares that generally vest after three years based on metrics and time-based RSUs that vest in three equal annual installments.
On commencement, he will receive time-based RSUs with a targeted grant-date value of $1,400,000 vesting in four equal annual installments beginning January 5, 2027, plus a $50,000 cash payment within one week of his start, repayable if he voluntarily leaves within one year. A consulting agreement runs October 20–December 31, 2025 at $375/hour for up to 30 hours per week. He is expected to relocate near Thomasville, GA by August 31, 2026 with relocation benefits subject to pro‑rata repayment under specified conditions.
Flowers Foods, Inc. director Sterling A. Spainhour Jr. reported an amended Form 4 showing a grant of 7,900 deferred shares dated 10/01/2025 under the 2014 Omnibus Equity and Incentive Compensation Plan (amended May 25, 2023). The deferred shares carry no conversion or exercise price and are recorded as representing 7,900 underlying common shares beneficially owned following the transaction. The record shows a date listed as exercisable on 05/21/2026 and a note indicating no expiration date. The filing was amended to add a confirming statement and is signed by an agent on 10/06/2025.
The Form 4 shows that Sterling A. Spainhour Jr., a director of Flowers Foods, Inc. (FLO), was awarded 7,900 deferred shares on 10/01/2025 under the company’s 2014 Omnibus Equity and Incentive Compensation Plan (amended May 25, 2023). The deferred shares carry no conversion or exercise price and the filing describes them as having no expiration date. The awards are listed as direct ownership, leaving Mr. Spainhour with 7,900 shares beneficially owned following the transaction. The deferred shares are noted as dated exercisable 05/21/2026 in the table of derivative securities, and the filing states the grant is governed by the company’s Deferred Shares Agreement for Directors.